
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
SPACR CRISPR/Cas9 KO Plasmid (h) | sc-406681 | 20 µg | $397.00 |
IMPG1 encodes SPACR, a large secreted proteoglycan that is a key structural component of the retinal interphotoreceptor matrix and contributes to adhesion and spacing between photoreceptor outer segments and the retinal pigment epithelium. Through extensive glycosylation and interactions with other extracellular matrix constituents, SPACR supports matrix organization, diffusion of signaling molecules, and maintenance of photoreceptor homeostasis. Disruption of IMPG1 is associated with inherited retinal disorders, including macular dystrophies, highlighting its relevance to studies of extracellular matrix integrity and photoreceptor survival pathways. As a retina-enriched matrix protein, SPACR is also used to investigate how pericellular matrices modulate cell–cell communication and stress responses in the neuroepithelium.
SPACR CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the IMPG1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the IMPG1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the IMPG1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish SPACR protein expression.
This CRISPR knockout system enables efficient generation of IMPG1-deficient cell models for investigation of SPACR signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.